R.H. Investment Group LLC Acquires New Position in The Clorox Company (NYSE:CLX)

R.H. Investment Group LLC bought a new position in The Clorox Company (NYSE:CLX) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 2,000 shares of the company’s stock, valued at approximately $325,000. Clorox makes up about 0.3% of R.H. Investment Group LLC’s portfolio, making the stock its 28th biggest holding.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Catalyst Capital Advisors LLC purchased a new stake in shares of Clorox in the third quarter worth $54,000. AQR Capital Management LLC increased its stake in Clorox by 8.6% in the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company’s stock worth $39,121,000 after buying an additional 22,676 shares in the last quarter. Los Angeles Capital Management LLC raised its holdings in Clorox by 5.6% during the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after acquiring an additional 10,149 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its position in shares of Clorox by 60.5% in the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,769 shares of the company’s stock valued at $3,244,000 after acquiring an additional 8,957 shares in the last quarter. Finally, Canada Pension Plan Investment Board lifted its position in shares of Clorox by 1.6% in the second quarter. Canada Pension Plan Investment Board now owns 353,394 shares of the company’s stock valued at $48,228,000 after acquiring an additional 5,500 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.9 %

CLX opened at $158.95 on Wednesday. The stock has a 50-day moving average of $164.48 and a 200 day moving average of $156.16. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The firm has a market cap of $19.67 billion, a P/E ratio of 55.38, a P/E/G ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the previous year, the business earned $0.49 EPS. The company’s quarterly revenue was up 27.0% on a year-over-year basis. As a group, research analysts forecast that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.07%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is currently 170.03%.

Analyst Upgrades and Downgrades

CLX has been the topic of several recent analyst reports. JPMorgan Chase & Co. lifted their target price on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Evercore ISI reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and raised their target price for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $157.46.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.